In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, discusses the recent Techbio Boost event hosted by KQ Labs and the BIA, highlighting the programme's role in supporting the growth of London-based techbio seed and pre-series A companies.
In this blog, Dr Emma Lawrence, Senior Policy and Public Affairs Manager, BIA, shares more about the launch of our new inaugural Data, AI and Genomics Advisory Committee, a key initiative to support the growing techbio community in the UK.
With a little over eight weeks to go to London Life Sciences Week (LLSW), we are launching a new website - lifesciencesweek.london - and lifting the lid on all that is happening to make the UK the place to be for life sciences this November. Continue reading for updates on NHS, £12 million Innovate UK funding, and more!
This year RNID have been chosen as the BIA’s charity partner of the year. This partnership gives us a unique platform to shine the light on the huge opportunities that exist for hearing therapeutics.
With the Prime Minister calling a snap election set for 4 July, the BIA’s attention has turned to preparing for the next government. Meanwhile, Parliament Day, our flagship day of parliamentary engagement, has been postponed to the autumn. Official engagements with civil servants have also been restricted in accordance with the pre-election period of sensitivity.
UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.
With a general election widely expected to be called later this year, the BIA’s long-established relationships with senior parliamentarians have been of particular importance this quarter. From launching the Labour Party’s Life Science Sector Strategy in Stevenage in January to hosting Science Minister Andrew Griffith MP at our Gala Dinner, we continue to represent the sector at the highest levels.
Herbie Lambden, Senior Policy and Public Affairs Executive at the BIA, provides a rundown of the BIA Committee Summit, which took place in Westminster on 21 February.
The BIA has coined the term ‘Deep Biotech’ to capture companies working in this biotech space. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.
Brainomix's software is an award-winning imaging biomarker that uses mathematical algorithms to extract information from medical images, to enable precision medicine for better treatment decisions in stroke and lung fibrosis.
The BioIndustry Association (BIA) continued to represent the innovative life science and biotech sector to Ministers and senior policymakers between July and October 2023.
TechBio 2023: UK driving the AI revolution, a new report by the BioIndustry Association (BIA) highlights the UK TechBio sector as thriving, with a growing number of companies pioneering groundbreaking products and services, seamlessly integrating biotechnology and technology.
As the ‘back to school’ emails start to roll in and we come to terms with the end of summer, at BIA we are putting the finishing touches to a packed autumn agenda of events and thought leadership. With September just around the corner, it’s worth having a look at what we have planned and ensuring you book your place or get in touch to find out more.
